Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ttnguyen
    Member
    • Mar 2010
    • 41

    #1

    High GC content and PCR duplicate

    Dear All,

    Our lab used ChIP-seq to study a histone variant that is expected to occurs everywhere in the human genome. I found two problems with our ChIP-seq dataset but could not figure out why they happened.

    - I used Picard to mark duplicates and found that the duplicate percentage is 66%. I think this is so high. Do you know what is acceptable duplicate level in ChIP-seq data?

    - The GC content of our dataset is 56% - much higher than the GC content of the reference genome. However, this is not explained by the duplication problem since the GC content of this dataset after removing duplicates does not decrease. I saw a post saying that Illumina prefer to sequencing higher GC content region. I wonder if Illumina have already fixed this bias?

    I would very much appreciate if you could give some possible reasons for these two problems.

    Many thanks,

    Nguyen

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...